Status and phase
Conditions
Treatments
About
This is an individually randomized controlled trial to assess the effect of multiple micronutrient supplements (MMS) containing 60 and 45 mg iron as compared to MMS containing 30 mg of iron (standard UNIMMAP formulation) on maternal moderate or severe anemia. This study will help inform countries like Tanzania that currently use IFA containing 60 mg of iron regarding the dose of iron to use in MMS.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
6,381 participants in 3 patient groups
Loading...
Central trial contact
Christopher R Sudfeld, ScD, ScM; Emily R Smith, ScD, MPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal